Introduction
============

Red blood cells, or erythrocytes, carry hemoglobin to supply oxygen to all tissues and organs. Approximately 2 × 10^13^erythrocytes circulate throughout the whole body. In humans, more than 10^11^new erythrocytes are generated daily from bone marrow (BM) through a process known as erythropoiesis \[[@B1]\]. In the BM, the hierarchy of erythropoiesis is topped by hematopoietic stem cells (HSCs), which first differentiate into common myeloid and common lymphoid progenitors. Common lymphoid and myeloid progenitors give rise to the adaptive and innate immune systems, respectively. Common myeloid progenitors differentiate into megakaryocyte/erythroid progenitors and granulocyte/monocyte progenitors. At the same time, common lymphoid progenitors differentiate into B lymphocytes, T lymphocytes, and natural killer cells. Megakaryocyte/erythroid progenitors later give rise to erythrocytes or thrombocytes (platelets), whereas granulocyte/monocyte progenitors give rise to granulocytes (neutrophils, eosinophils, and basophils), monocytes, and dendritic cells (Figure [1](#F1){ref-type="fig"}). Erythrocytes synthesize hemoglobin, which is composed of two β-globin subunits and two α-globin subunits that interact with an iron-containing heme moiety. Intrinsic transcription factors and extrinsic signaling molecules coordinately regulate erythroid differentiation and hemoglobin synthesis. Impaired erythrocyte production or hemoglobin synthesis results in anemia and decreases the oxygen supply throughout the body, a condition known as hypoxia. Much of what we know about human erythropoiesis and anemic diseases comes from studies using animal models such as *Xenopus*, zebrafish, chicks, and mice \[[@B2]-[@B5]\].

![**Schematic representation of hematopoiesis in mouse and human bone marrow**. Erythropoiesis is shown in the blue box. CLP, common lymphoid progenitor; CMP, common myeloid progenitor; GMP, granulocyte-macrophage progenitor; HSC, hematopoietic stem cell; MEP, megakaryocyte-erythroid progenitor.](scrt146-1){#F1}

Zebrafish (*Danio rerio*) is a teleost freshwater fish widely distributed throughout tropical and subtropical areas of South Asia, including India, Nepal, Bangladesh, and Northern Burma \[[@B6]\]. Zebrafish are known worldwide as models for the study of development, cell biology, physiology, and genetics. *In vivo*analyses using zebrafish have some advantages over those using mice. First and foremost, zebrafish produce large numbers of small-sized embryos, permitting drug screening and functional analysis of specific genes on a large scale. Second, zebrafish have a short life span (42 to 66 months) \[[@B7]\] and develop rapidly, requiring 90 days to develop into adults \[[@B7]\], shortening periods required for experiments. Third, zebrafish embryos are transparent and develop outside a uterus, enabling researchers to view zebrafish development and genetically manipulate embryos under a microscope. Finally, many zebrafish gene functions are conserved in mice and humans, enabling researchers to translate results obtained in zebrafish studies to mammalian contexts. Currently, through large-scale mutagenesis, several models of human anemic diseases have been established in zebrafish, enabling us to develop novel therapies in anemias.

1. Development of zebrafish erythropoiesis
==========================================

Like the generation of other blood cell types, zebrafish erythropoiesis takes place in the mesodermal germ layer and is classified into two sequential waves: primitive and definitive. The primitive wave generates erythrocytes and macrophages during embryonic development, whereas the definitive wave produces definitive HSCs, which can differentiate into every blood cell type (namely, erythrocytes, granulocytes, lymphocytes, and platelets), and maintains homeostasis throughout the zebrafish lifetime (Figure [2](#F2){ref-type="fig"}). To understand how erythropoiesis develops embryonically and is maintained in the adult, we also discuss the origin of erythrocytes from HSCs.

![**Comparative timeline of embryonic zebrafish and mouse hematopoiesis**. From 12 to 24 hours post fertilization (hpf), primitive hematopoietic cells (proerythroblasts, erythroblasts, and macrophage precursors) appear in the intermediate cell mass, which is equivalent to the mouse yolk sac, from embryonic day (E) 7.5 to E10.0. After blood circulation starts at 24 hpf, primitive hematopoietic cells enter the circulation and mature. From 26 to 48 hpf, definitive hematopoietic precursors emerge from endothelial cells lining the ventral wall of dorsal aorta. The space between the dorsal aorta and axial vein is equivalent to the mouse aorta-gonad-mesonephros (AGM) region (E10.5 to E12.5). At 2 to 6 days post fertilization (dpf), definitive hematopoietic precursors enter the circulation, colonize, and expand in the caudal hematopoietic tissue, which is equivalent to mouse fetal liver (E11.5 to E18.5). In fish, hematopoiesis then shifts to the kidney and thymus. In the mouse, hematopoiesis shifts from fetal liver to bone marrow at E18.0. At 3 dpf, lymphoblasts appear in the thymus and differentiate into T lymphocytes. In fish, all hematopoietic lineages appear in the kidney marrow at 4 dpf, whereas B lymphocytes appear at 19 dpf. Thus, the kidney marrow and thymus are major hematopoietic organs throughout the lifespan of adult zebrafish. Sites where erythropoiesis occurs are shown by red boxes.](scrt146-2){#F2}

1.1. Primitive erythropoiesis
-----------------------------

The fertilized egg, or zygote, divides and forms three germ layers: ectoderm, mesoderm, and endoderm; this process is known as gastrulation. Mesoderm gives rise to muscle, notochord, hematopoietic cells, pronephros, and blood vessels. Mesoderm is divided into dorsal and ventral mesoderm. Dorsal mesoderm develops into the notochord, whereas ventral mesoderm gives rise to hematopoietic cells, the pronephros, and blood vessels. Primitive hematopoiesis intraembryonically starts in ventral mesoderm-derived tissue, known as the intermediate cell mass (ICM) (Figures [2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}). The ICM is located between the somites and yolk sac and consists of anterior and posterior ICM (Figure [3](#F3){ref-type="fig"}). At the two-somite stage, which is equivalent to 10 to 11 hours post fertilization (hpf), genes encoding transcription factors required for hematopoietic cell specification, such as T-cell acute lymphocytic leukemia 1 (*tal1*), GATA-binding protein 2a (*gata2a*), and LIM domain only 2 (*lmo2*), and vasculogenesis, such as ets variant gene 2 (*etv2*), are co-expressed in both the anterior and posterior ICM, implying the existence of a common ancestor of hematopoietic and endothelial cells, known as the hemangioblast \[[@B8]-[@B10]\] (Figure [4](#F4){ref-type="fig"}). These genes are highly conserved among vertebrates \[[@B10]-[@B13]\]. Among proteins encoded by these genes, tal1, previously known as stem cell leukemia (scl), is a basic helix-loop-helix transcription factor required for both primitive and definitive hematopoiesis as well as endothelial cell differentiation, whereas gata2a is a zinc finger transcription factor functioning in proliferation and maintenance of hematopoietic progenitor cells (HPCs). Zebrafish lmo2 is an LIM domain transcription factor that interacts with tal1 and gata2a, forming a DNA-binding complex, which activates the transcription of both hematopoietic and endothelial genes \[[@B10]\]. Zebrafish etv2, previously known as ets1-related protein (etsrp), is an E-twenty six (ets) domain-containing factor that activates transcription of endothelial-specific genes essential for vasculogenesis \[[@B11]\]. The posterior ICM expresses GATA-binding protein 1a (*gata1a*), which encodes an erythroid-specific transcription factor, and spleen focus-forming virus (*SFFV*) proviral integration oncogene spi1 (*spi1*), which encodes a myeloid-specific transcription factor, whereas the anterior ICM expresses only *spi1*\[[@B12],[@B13]\]. These studies suggest that the ICM has been committed to erythroid and myeloid lineage. Between 12 and 24 hpf, the anterior ICM develops into myeloid cells (macrophages), whereas the posterior ICM develops primarily into erythroid and some myeloid cells (Figure [3](#F3){ref-type="fig"}).

![**Anatomical sites of primitive and definitive hematopoiesis**. The anterior and posterior intermediate cell masses (ICMs) are sites of primitive hematopoeisis, whereas the aorta-gonad-mesonephros (AGM)-like region, caudal hematopoietic tissue (CHT), thymus, and pronephros are sites of definitive hematopoiesis. Blood cell types that arose from each hematopoietic site are indicated. The AGM-like region is located between the dorsal aorta and axial vein. Hematopoietic stem cells (HSCs) and hematopoietic progenitor cells (HPCs) emerge from the AGM-like region and enter the blood circulation via the axial vein. HSCs and HPCs expand in the CHT and then migrate to the thymus and pronephros. Anatomical sites of erythropoiesis are shown in the red-framed boxes. YS, yolk sac.](scrt146-3){#F3}

![**Schematic of primitive and definitive hematopoiesis during zebrafish embryogenesis**. Cells functioning in both primitive and definitive hematopoiesis are derived from mesoderm. After gastrulation, hemangioblasts in the intermediate cell mass (ICM) differentiate into either primitive hematopoietic stem cells (HSCs) and hematopoietic progenitor cells (HPCs) or vascular endothelial cells. Primitive HSCs and HPCs give rise to erythrocytes, granulocytes, and macrophages. For definitive hematopoiesis, HSCs and HPCs emerge from hemogenic endothelial cells lining the ventral wall of dorsal aorta in the aorta-gonad-mesonephros (AGM)-like region. Definitive HSCs and HPCs enter the circulation and migrate to the caudal hematopoietic tissue, thymus, and pronephros, where they differentiate into erythroid/myeloid progenitors or lymphoid progenitors. Those progenitors further differentiate into the indicated cell types. Primitive erythropoiesis and definitive erythropoiesis are highlighted in blue boxes. Transcription factors critical for HPCs and erythroid/myeloid progenitor cells are shown in blue in italics. *cmyb*, transcription factor cmyb; *csf1ra*, colony-stimulating factor 1 receptor a; *gata1a*, GATA-binding protein 1a; *gata2a*, GATA-binding protein 2a; *runx1*, runt-related transcription factor 1; *spi1*, spleen focus-forming virus proviral integration oncogene spi1; *tal1*, T-cell acute lymphocytic leukemia.](scrt146-4){#F4}

At 20 to 24 hpf, primitive erythroid cells (proerythroblasts and erythroblasts) expressing *gata1a*are present in the posterior ICM \[[@B14]\] (Figure [2](#F2){ref-type="fig"}). Similar to the mam-malian yolk sac, primitive erythroid cells are surrounded by endothelial cells \[[@B15]\]. After the onset of blood circulation at 24 hpf, *gata1a*^+^primitive erythroid cells migrate throughout the embryo and dierentiate into mature erythrocytes expressing aminolevulinate, delta-, synthetase 2 (*alas2*), which is an enzyme required for heme synthesis, and embryonic globin genes \[[@B16]\]. Unlike similar cells in humans and mice, zebrafish erythrocytes are nucleated and oval in shape (Figure [4](#F4){ref-type="fig"}). Primitive erythropoiesis accounts for all circulating erythrocytes for the first 4 days after fertilization \[[@B15]\].

In zebrafish, primitive erythropoiesis is regulated intrinsically by transcription factors expressed in erythroid cells and extrinsically by erythropoietin secreted from surrounding cells and tissues. Zebrafish gata1a, a zinc finger transcription factor, activates the expression of erythroid-specific genes functioning in hemoglobin synthesis, iron utilization, and cell membrane stabilization. Gata1a also suppresses the expression of myeloid-specific genes \[[@B14]\]. As in the mouse, a nonsense mutation in the gene encoding zebrafish gata1a results in a lack of circulating erythrocytes at 26 hpf \[[@B17]\], suggesting a conservation of gata1a function among vertebrates. Unlike in the mouse, zebrafish primitive erythropoiesis depends on the extrinsic factor erythropoietin (epo). *Epo*and *erythropoietin receptor*(*Epor*) mRNA is detected in the ICM during 16 to 24 hpf. Knockdown of *Epor*impairs primitive erythropoiesis in fish \[[@B18]\].

1.2. Definitive erythropoiesis
------------------------------

In mice, definitive HSCs are defined as having the ability to reconstitute all blood cell types in lethally irradiated adult mice. Definitive HSCs are first detected in the aorta-gonad-mesonephros (AGM) region \[[@B19]\] and umbilical vessels \[[@B20]\] at mouse embryonic day 10 or 11. Definitive HSCs enter the blood circulation and colonize fetal liver, the first site of definitive hematopoiesis, where they expand and differentiate into erythroid and myeloid cells.

In zebrafish, an AGM-like region exists along the trunk in the space between the dorsal aorta and the underlying axial vein \[[@B21]-[@B24]\] (Figure [3](#F3){ref-type="fig"}). Cell-tracking and time-lapse imaging analyses indicate that HSCs and HPCs originate directly from the ventral wall of dorsal aorta (VDA) at 26 hpf (Figure [2](#F2){ref-type="fig"}) \[[@B24],[@B25]\]. The morphology of endothelial cells lining the VDA changes from a long flat shape to a round shape, and the cells egress into the subaortic space and enter the blood circulation via the axial vein (Figure [3](#F3){ref-type="fig"}), a process called endothelial-to-hematopoietic transition \[[@B24]\]. As in mammals, runt-related transcription factor 1 (runx1) is critical for the emergence of hematopoietic cells from endothelial cells \[[@B26]\]. At 24 hpf, *runx1*-expressing HSCs and HPCs are observed in the VDA \[[@B27]\]. Later, at 26 hpf, dorsal aorta-derived *runx1*^+^HSCs and HPCs start to express the transcription factor *cmyb*\[[@B28]\], which is required for HSC migration and differentiation but not for the endothelial-to-hematopoietic transition in zebrafish \[[@B29]\]. Later, *cmyb*^+^HSCs and HPCs express integrin alpha 2b (*itga2b*), also known as *CD41*\[[@B30]\]. As in the mouse, CD41 is the earliest HSC and HPC surface marker seen in endothelial cells lining the dorsal aorta. Dorsal aorta-derived CD41^+^HSCs and HPCs enter the blood circulation via the axial vein rather than the dorsal aorta and colonize caudal hematopoietic tissue by 48 hpf (Figure [3](#F3){ref-type="fig"}) \[[@B30]\]. This tissue, also known as the caudal vein plexus, is highly vascularized. From 48 hpf to 7 days post-fertilization (dpf), *cmyb*^+^HSCs and HPCs expand and differentiate into erythrocytes, mono-cyte/macrophages, and thrombocytes in caudal hematopoietic tissue (Figures [2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}). Therefore, caudal hematopoietic tissue exhibits properties similar to those of the mammalian fetal liver. Next, HSCs and HPCs migrate from the caudal hematopoietic tissue first to the thymus and then to the pronephros \[[@B21]-[@B23]\] (Figure [2](#F2){ref-type="fig"}). CD41^+^HSCs and HPCs first appear in the thymus at 54 hpf (2.25 dpf) \[[@B23]\], and by 4 dpf, *cmyb*^+^HSCs and HPCs appear in the pronephros (Figure [2](#F2){ref-type="fig"}), which later develops into the kidney and functions equivalently to mammalian BM \[[@B21],[@B22]\]. Two routes of HSC migration from the AGM-like region to the pronephros have been proposed: the first to caudal hematopoietic tissue and pronephros via the circulation (Figure [3](#F3){ref-type="fig"}) and the second directly from the AGM-like region via the pronephric tubules \[[@B30]\]. At 4 dpf, only myeloerythroid lineages have progressively expanded in the kidney \[[@B15]\]. By 7 dpf, erythroblasts are found in the kidney \[[@B15]\], where they later become the major definitive hematopoietic organ of adult zebrafish.

2. Erythropoiesis in adult zebrafish
====================================

In mammals, adult erythropoiesis is maintained primarily in the BM. HSCs differentiate into erythroid progenitor cells and later erythroblasts. Subsequently, erythroblasts undergo terminal differentiation into mature erythrocytes. Mature erythrocytes are spherical and biconcave with a typical size of 7 to 8 μm. As in embryos, cell-extrinsic cues, such as erythropoietin, and cell-intrinsic cues, such as erythroid-specific transcription factors Gata1 and Kruppel-like factor 1 (Klf1), coordinately regulate erythropoiesis in the BM \[[@B31]\].

Unlike in mammals, zebrafish erythropoiesis is maintained in the interstitium of the anterior and posterior kidney \[[@B2]\]. In adult kidney marrow, common myeloid progenitors differentiate into megakaryocyte/erythroid progenitors expressing the transcription factor gata1a, an ortholog of mouse Gata1. The megakaryocyte/erythroid progenitors differentiate into erythroblasts. Erythroblasts later differentiate into mature erythrocytes, which are elliptical and nucleated cells with a typical size of 7 × 10 μm \[[@B32]\].

Although kidney marrow erythrocytes can be fractionated from blood cell mixtures by flow cytometry based on forward and side scatter (which reveal cell size and granularity, respectively), their surface markers have not been fully identified \[[@B33]\]. Although some potentially useful antibodies cross-react among species, it remains a challenge to analyze erythroid cells by using antibody-based techniques, owing to a shortage of reagents.

As in mammals, zebrafish erythrocytes contain hemoglobin. Human and mouse α-globin and β-globin genes are located on separate chromosomes and arranged in order of embryonic and adult expression. The change from embryonic to adult globin expression is known as globin switching \[[@B34]\]. By contrast, zebrafish α-globin and β-globin genes are located on the same chromomsome and found in embryonic and adult clusters separated by non-coding genomic DNA \[[@B35]\]. The embryonic cluster consists of hemoglobin alpha embryonic-1 (*hbae1*) and hemoglobin beta embryonic-1.1 (*hbbe1.1*), whereas the adult cluster contains hemoglobin alpha adult-1 (*hbaa1*) and beta adult-1 globin (*ba1*). Moreover, in the adult cluster, globin genes are oriented in a head-to-head pattern: 3\'-5\' in the case of *α-globin*and 5\'-3\' in the case of *β-globin*genes. Thus, they are transcribed in the opposite direction \[[@B36]\]. High-performance liquid chromatography analysis shows that adult zebrafish erythrocytes in peripheral blood contain three major α-globin and two β-globin proteins \[[@B36]\]. As in mammals, globin switching also occurs during zebrafish development at a stage 10 dpf \[[@B36]\]. As in embryos, adult zebrafish erythropoiesis is regulated by extrinsic and intrinsic cues.

2.1. Zebrafish erythropoietin
-----------------------------

Erythropoietin (Epo) is a glycoprotein crucial for survival and proliferation of erythroid progenitor cells. In mammals, there is only one Epo that is primarily produced from kidney and BM \[[@B37]\]. Binding of EPO to its receptor activates Janus kinase/signal transducer and activator of transcription 5 (JAK/STAT5) signaling pathway, which upregulates anti-apoptotic genes and promotes cell survival \[[@B31]\]. Mammalian EPO is not required for primitive erythropoiesis but is indispensable for definitive erythropoiesis \[[@B38],[@B39]\].

Unlike the case in mice, erythropoiesis of both primitive and definitive zebrafish depends on erythropoietin signaling \[[@B18]\]. Unlike the case with the mammalian *Epo*gene, there are three splice variants of *epo*gene in fish: *epo-L1, epo-L2*, and *epo-S*\[[@B40]\]. *epo-L1*and *epo-L2*are expressed predominantly in the heart and liver, whereas *epo-S*is expressed in adult kidney marrow \[[@B40],[@B41]\]. The C-terminal amino acid sequences of proteins encoded by these genes are identical, but the N-terminal signal peptides differ. Misexpression studies in the monkey kidney fibroblast COS-1 cell line indicate that epo-L1 and epo-L2 are secreted but that epo-S is cytosolic \[[@B40]\].

In mammals, decreased blood oxygen because of anemia or hypoxia induces EPO production in the kidney and accelerates erythropoiesis. Similarly, anemia and hypoxia upregulate the expression of zebrafish *epo*mRNA in the heart \[[@B18]\]. Moreover, zebrafish erythropoietin signaling requires stat5.1 protein, an ortholog of human STAT5 \[[@B18]\]. Th ese observations demonstrate that epo/epor function is highly conserved among vertebrates.

2.2. Zebrafish erythroid transcription factors
----------------------------------------------

In the mouse, Gata1 regulates transcription of erythropoietic genes, including Klf1. Gata1 knockout mice die during gestation because of severe anemia \[[@B42]\]. Like Gata1, mouse Klf1 is essential for definitive erythropoiesis in fetal liver \[[@B43]\]. Klf1 reportedly regulates the expression of several erythroid-specific genes encoding (a) globin, (b) enzymes for heme biosynthesis, and (c) erythroid membrane and cytoskeletal proteins \[[@B44]\].

Little is known about the role of gata1a in adult erythropoiesis because of the lethal phenotype of null mutants at an early stage of development \[[@B17]\]. In addition, no functional ortholog of mouse Klf1 has been identified in zebrafish. Although the zebrafish *klfd*gene is expressed in both primitive and definitive erythropoietic organs \[[@B45]\] and the amino acid sequence of zebrafish klfd is similar to that of mouse Klf1 \[[@B45]\], there is currently no direct evidence that klfd functions in definitive erythro-poiesis. Zebrafish *klf4*knockdown using antisense morpholino oligonucleotides downregulates the expression of embryonic *β-globin*and genes involved in heme biosynthesis, but no defect is seen in definitive erythropoiesis \[[@B46]\]. Therefore, it is unlikely that klf4 is the ortholog of mouse Klf1. Thus, owing to the lack of a model, the roles of gata1a and klfd in adult erythropoiesis have not been clarified. These outcomes prompted us to establish transient and reversible downregulation of both transcription factors in adult zebrafish, as discussed in section 3.8.

3. Zebrafish as models of human erythropoiesis-related diseases
===============================================================

Zebrafish erythropoietic genes are functionally similar to those expressed in mice and humans and include genes encoding enzymes for heme biosynthesis, structural erythrocyte membrane proteins, epo/epo receptor, and globin \[[@B47]\]. Large-scale mutagenesis of zebrafish has enabled the identification of genes regulating hemato-poiesis/erythropoiesis \[[@B32],[@B48]\]. The human homologs of some of these genes function in hematological diseases \[[@B3]\]. Zebrafish are advantageous for evaluating the function of genes underlying erythropoietic disease since fish embryos are resistant to severe anemic conditions because of passive diffusion of oxygen into the fish. Fish models of human anemias (Table [1](#T1){ref-type="table"}) are described below. Many of the following mutants could be useful to test new drugs.

###### 

Zebrafish mutant strains relevant to human erythropoiesis-related diseases

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Human disease                                          Mutant          Gene                                                     Function                                      Reference
  ------------------------------------------------------ --------------- -------------------------------------------------------- --------------------------------------------- ------------
  Erythropoietic protoporphyria                          *dracula*       Ferrochelatase                                           Enzyme functioning in heme synthesis          \[[@B50]\]

  Hemolytic anemia                                       *merlot*        Erythrocyte membrane protein 4.1R                        Structural protein of erythrocyte membrane\   \[[@B54]\]
                                                                                                                                  Stabilizes β-spectrin/actin interaction       

  Congenital dyserythropoietic anemia type II (HEMPAS)   *retsina*       Solute carrier family 4 (anion exchanger 1a or band 3)   Chloride exchanger                            \[[@B56]\]

  Hereditary spherocytosis                               *riesling*      β-spectrin                                               Structural protein of erythrocyte membrane    \[[@B59]\]

  Congenital sideroblastic anemia                        *sauternes*     Aminolevulinate synthetase 2 (alas2)                     Enzyme functioning in heme synthesis          \[[@B63]\]

  Hypochromic anemia\                                    *zinfandel*     Globin                                                   Oxygen transport                              \[[@B35]\]
  (resembles thalassemia)                                                                                                                                                       

  Type IV hemochromatosis                                *weissherbst*   Ferroportin 1                                            Iron transport                                \[[@B65]\]
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

HEMPAS, hereditary erythroblastic multinuclearity with positive acidified serum lysis test.

3.1. Erythropoietic protoporphyria
----------------------------------

Erythropoietic protoporphyria occurs worldwide, has a prevalence of 1:75,000 in The Netherlands \[[@B49]\], and is caused by ferrochelatase deficiency. Ferrochelatase catalyzes the formation of heme by transferring iron to protoporphyrin, a heme intermediate. Mutations in the human ferrochelatase gene promote protoporphyrin accumulation in the skin, erythrocytes, and liver, resulting in sensitivity to light exposed to the skin or even erythrocytes and skin burning and itching \[[@B49]\]. Among patients, 20% to 60% also exhibit anemia due to decreased heme synthesis and light-dependent erythrocyte lysis. Some patients (1% to 4%) show liver disease due to the accumulation of free protoporphyrin released from lysed erythrocytes \[[@B49]\]. Although the avoidance of sun exposure and treatment with light-protective substances such as β-carotene and melanin in skin can ameliorate symptoms, no curative treatment is yet available \[[@B49]\].

The zebrafish mutant *dracula*exhibits a point mutation in the ferrochelatase gene, creating an in-frame stop codon and expression of a dysfunctional enzyme. *Dracula*fish manifest autofluorescent erythrocytes, light-dependent hemolysis, and liver malfunction, similar to conditions seen in humans \[[@B50]\]. Owing to the transparency of fish embryos and protoporphyrin autofluorescence, protoporphyrin accumulation can be monitored microscopically in various organs of an intact fish, an analysis impossible in humans and mice, making *dracula*mutants a suitable model for human erythropoietic protoporphyria.

3.2. Hemolytic anemia
---------------------

Abnormality of erythroid cell membrane leads to massive erythrocyte destruction in the spleen, a condition known as hemolytic anemia. Human hereditary elliptocytosis is characterized by elliptical erythrocytes, in which abnormal cell membranes lead to hemolytic anemia. Human hereditary elliptocytosis occurs worldwide but is prevalent in West Africa \[[@B51]\]. Often patients show no symptoms, and only 10% have mild to severe anemia \[[@B51]\]. In human hereditary elliptocytosis, many patients harbor point mutations in the gene encoding protein 4.1R, a major component of the erythrocyte cytoskeleton that maintains biconcave morphology. These mutations promote decreased protein expression or impair protein interaction with other cytoskeletal proteins \[[@B52]\]. Owing to massive hemolysis, patients with hereditary elliptocytosis have complications such as cardiomegaly, splenomegaly, and gallstones. Only supportive treatments, such as folate therapy, blood transfusion, splenectomy, and gallstone removal, are currently available \[[@B51],[@B53]\]. Although HSC transplantation is one curative therapy, novel drugs are needed to antagonize hemolysis.

The zebrafish *merlot*mutant exhibits severe hemolytic anemia due to mutation in the gene encoding 4.1R protein. Unlike mammalian erythrocytes, wild-type mature zebrafish erythrocytes exhibit both spherical and elliptical morphologies. *Merlot*mutants show spiculated erythrocyte membranes, resulting in hemolytic anemia and conditions such as cardiomegaly and splenomegaly, phenotypes similar to those seen in humans \[[@B54]\].

3.3. Congenital dyserythropoietic anemia type II
------------------------------------------------

Human congenital dyserythropoietic anemia type II is an erythroid-specific abnormality in cell division, leading to multinuclear erythroblasts, erythroblast apoptosis (dyserythropoiesis), and anemia. The condition varies from mild to severe: approximately 15% of patients require blood transfusions during infancy and early childhood but not thereafter \[[@B55]\]. Splenomegaly occurs in 50% to 60% of patients, and gallstones are frequently observed. In the BM, 10% to 45% of erythroblasts are bi- and multinucleated \[[@B55]\]. Dyserythropoiesis is caused by a mutation in the anion exchanger protein band 3, which is present in the human erythrocyte membrane \[[@B55]\]. The zebrafish *retsina*mutant exhibits erythroid-specific defects in cell division because of mutation in the fish ortholog of the band 3 gene. These defects resemble those of the human disease \[[@B56]\]. Severely affected anemic patients require blood transfusion and HSC transplantation \[[@B57]\].

3.4. Hereditary spherocytosis
-----------------------------

Human hereditary spherocytosis is a hemolytic anemia common in Caucasians and has a prevalence of 1:2,000 to 1:5,000 \[[@B53]\]. Hereditary spherocytosis is characterized by abnormal erythrocyte morphology. Normally, the shape of human erythrocytes is a biconcave disk. In hereditary spherocytosis, the erythrocytes exhibit a spherical shape, leading to their massive destruction in the spleen. Mutation in the gene encoding the cytoskeletal protein spectrin has been identified as a cause of human hereditary spherocytosis. Erythroid spectrin stabilizes membrane bilayers \[[@B58]\]. Anemia ranging from mild (blood transfusion-independent) to severe (blood transfusion-dependent) is the main clinical feature of this condition. Patients also exhibit hyperbilirubinemia, causing jaundice, and splenomegaly. The zebrafish *riesling*carries a mutant *β-spectrin*gene and exhibits anemia due to erythrocyte hemolysis, similar to conditions seen in humans \[[@B59]\]. Zebrafish β-spectrin shares 62.3% identity with the human ortholog. In addition to exhibiting abnormal cell morphology-induced hemolysis, zebrafish *riesling*erythrocytes undergo apoptosis, which had not been observed in human hereditary spherocytosis. Thus, analysis of the zebrafish *riesling*mutant has revealed a novel mechanism of erythrocyte hemolysis \[[@B59]\].

3.5. Congenital sideroblastic anemia
------------------------------------

Human congenital sideroblastic anemia is characterized by iron deposition in mitochondria of erythroblasts in the BM and is caused by a mutation in the gene encoding δ-aminolevulinate synthase, or ALAS2, which catalyzes the first step of heme biosynthesis. A lack of heme promotes increases in free iron levels and subsequent iron deposition in erythroblast mitochondria, causing insufficient production of mature erythrocytes \[[@B60]\]. Generally, patients have symptoms of anemia, such as skin paleness, fatigue, dizziness, and enlargement of the spleen and liver. In addition to a decrease of mature erythrocytes, hypochromic microcytic erythrocytes are observed in the patients. Heme reportedly promotes gene expression of *β-globin*through binding Batch1, a transcriptional repressor of *β-globin*gene \[[@B61],[@B62]\]. Therefore, decreased intracellular heme because of mutated ALAS2 may contribute to hypochromic microcytic anemia. Mutation in the zebrafish gene *sauternes*, which encodes alas2 protein, results in a condition similar to hypochromic microcytic anemia in humans \[[@B63]\]. *Sauternes*mutant embryos show delayed erythrocyte maturation and decreased β-globin expression. These mutants represent the first animal model to allow the investigation of mechanisms underlying heme-induced globin synthesis.

3.6. Hypochromic anemia
-----------------------

Hypochromic anemia is a general term for anemia in which erythrocytes look paler and smaller than they do normally. In humans, hypochromic anemia results from reduction in either globin synthesis (as occurs in thalassemia) or iron absorption (as occurs in iron deficiency) or from vitamin B~6~deficiency. In mammals and fish, different globin subtypes are expressed in embryonic and adult stages. In adult mammals, embryonic globin synthesis is suppressed whereas adult globin synthesis is activated \[[@B34]\]. Thalassemic patients show reduced adult globin synthesis and reactivate fetal globin expression, which can ameliorate anemia severity. The zebrafish *zinfandel*mutant exhibits hypochromic microcytic anemia due to defective embryonic globin production. This condition is rescued in adult fish once adult globin is produced \[[@B35]\].

3.7. Type IV hemochromatosis (iron overload)
--------------------------------------------

Type IV hemochromatosis, or iron overload, is characterized by increased intestinal iron absorption and progressive iron deposition in various tissues, resulting in hepatic cirrhosis, arthritis, cardiomyopathy, diabetes, hypopituitarism, and/or hyperpigmentation \[[@B64]\]. Its primary cause is mutation in genes encoding membrane proteins functioning in iron transportation, such as hemochromatosis protein, the transferrin receptor, and hemojuvelin. Analysis of zebrafish *weissherbst*mutants revealed mutations in a novel iron transporter, named ferroportin 1 \[[@B65]\]\--mutations later identified in patients with type IV hemochromatosis \[[@B66],[@B67]\].

3.8. Other anemias
------------------

As noted, most zebrafish mutant lines with defects in erythropoiesis were generated by mutagenesis by using ethylnitrosourea \[[@B32],[@B48]\]. These pioneering studies provided useful animal models of anemia and identified numerous genes underlying human anemias. Nonetheless, such screens take time and are expensive, prompting us to establish a novel, simpler anemic model.

It is known that temperature regulates hematopoiesis \[[@B68]\]. High temperature increases the number of hematopoietic cells in the BM of rats and the nine-banded armadillo (*Dasypus novemcinctus*), whereas low temperature has opposite effects \[[@B68]\]. However, in nature, zebrafish survive in a wide range of temperatures, from 6°C in winter to 38°C in summer \[[@B6]\], making them useful to investigate the effect of temperature on hematopoiesis. Previously, we established a novel reversible anemic model by keeping zebrafish at 17°C (cold zebrafish) \[[@B41]\]. By comparison with fish kept at a higher temperature (26.5°C), \'cold\' zebrafish appear paler starting at the first week of cold exposure (Figure [5a](#F5){ref-type="fig"}, right panel). The kidney marrow of cold zebrafish shows abnormally structured renal tubules and erythrocyte clusters (Figure [5b](#F5){ref-type="fig"}, right panel). We examined the expression of genes essential for HSC maintenance, erythropoiesis, and myelopoiesis by real-time polymerase chain reaction (PCR). Interestingly, only HSC-regulated genes (*runx1, cmyb, gata2a*, and *tal1*) (data not shown) and erythropoietic genes (*gata1a, klfd, epo, epor, hbaa1*, and *ba1*) (Figure [5c](#F5){ref-type="fig"}) were down-regulated the first week of exposure. These genes were expressed at generally lower levels by the second week, suggestive of anemia. However, expression of *colony-stimulating factor 1a*, which is required for macrophage differentiation, and of *colony-stimulating factor 3*(granulocyte), which is required for granulocyte differentiation, was unchanged \[[@B41]\]. These results suggest that cold exposure specifically suppresses erythropoiesis. Moreover, cold-induced anemia was reversed when fish were returned to 26.5°C conditions, implying that phenotypes are directly caused by temperature \[[@B41]\].

![**Zebrafish kidney marrow and effects of exposure to low temperature**. **(a)**Gross appearance of normal and cold zebrafish kept in 26.5°C or 17°C water, respectively, for 1 week. Dotted green line indicates location of anterior and posterior kidneys (arrows). **(b)**Histology of the kidney marrow of cold zebrafish stained with toluidine blue O. In 26.5°C water, hematopoietic cells (HCs) were observed between renal tubules (RTs) (left). Similarly aged zebrafish kept in 17°C water for 7 months exhibit abnormal RTs (right). Erythrocyte clusters (arrow) were observed only in the kidney marrow of cold zebrafish. **(c)**Expression of erythropoiesis-related genes in the kidney marrow of normal (26.5°C, white bars) and cold-exposed (17°C, gray bars) zebrafish. Gene expression was quantified by real-time polymerase chain reaction during the second week of cold exposure. Expression levels of genes encoding transcription factors important for erythropoiesis (*gata1a*and *klfd*), the adult hemoglobin gene α-globin (*hbaa1*), and β-globin (*ba1*) were downregulated, whereas the *epo*and *epor*expression levels were slightly decreased. Low expression of *hbaa1, ba1, klfd*, and *gata1a*indicates anemic status of cold zebrafish. These frames are modified from our previous report \[[@B41]\]. *ba1*, globin ba1; *epo*, erythropoietin; *epor*, erythropoietin receptor; *gata1a*, GATA-binding protein 1a; *hbaa1*, hemoglobin alpha adult-1; *klfd*, Kruppel-like factor d. These figures are modified from \[[@B41]\].](scrt146-5){#F5}

To further identify novel genes regulating erythropoiesis mediated by cold exposure, we assessed global changes in gene expression in the kidney marrow by DNA microarray (unpublished data). Although decreased temperature suppressed enzymatic activity and resulted in a global decrease in gene expression, we observed both increased and decreased gene expression in the kidney marrow of cold zebrafish, as confirmed by real-time PCR. We are now undertaking loss-of-function analysis of candidate factors by using antisense morpholino oligonucleotides and small interference RNAs in fish, and we are conducting gain-of-function analysis in mouse and human cell lines.

4. Conclusions
==============

Defects in erythropoiesis result in various anemic diseases. To gain an understanding of these diseases, it is necessary to determine how erythropoiesis is regulated in normal conditions as well as to establish *in vivo*models. We propose that, in addition to several anemic mutants, our cold zebrafish model is a useful tool to explore novel genes functioning in erythropoiesis. Given the advantages of zebrafish models, it is feasible to reach these objectives. Knowledge of the etiology and molecular mechanisms underlying these conditions will lead to the development of novel therapies.

Note
====

This article is part of a thematic series on *Stem cell research in theAsia-Pacific*edited by Oscar Lee, Songtao Shi, Yufang Shi, and Ying Jin. Other articles in the series can be found online at <http://stemcellres.com/series/asiapacific>.

Abbreviations
=============

AGM: aorta-gonad-mesonephros; *ba1*: globin ba1; BM: bone marrow; *cmyb*: transcription factor cmyb; dpf: days post-fertilization; epo: erythropoietin; Epor: *erythropoietin receptor*; *etv2*: ets variant gene 2; *gata1a*: GATA-binding protein 1a; *gata2a*: GATA-binding protein 2a; *hbaa1*: hemoglobin alpha adult-1; HPC: hematopoietic progenitor cell; hpf: hours post fertilization; HSC: hematopoietic stem cell; ICM: intermediate cell mass; klf: Kruppel-like factor; *lmo2*: LIM domain only 2; PCR: polymerase chain reaction; *runx1*: runt-related transcription factor 1; *spi1*: spleen focus-forming virus proviral integration oncogene spi1; stat5.1: signal transducer and the activator of transcription 5.1; *tal1*: T-cell acute lymphocytic leukemia; *VDA*: ventral wall of dorsal aorta.
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